Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphomaIn: Blood Advances, Jg. 6, 2022, Nr. 23, S. 5995 – 6004DOI (Open Access)
-
Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell LymphomaIn: Clinical Lymphoma, Myeloma & Leukemia, Jg. 22, 2022, Nr. 6, S. 382 – 392DOI (Open Access)
-
Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma : International Metabolic Prognostic IndexIn: Journal of Clinical Oncology (JCO), Jg. 40, 2022, Nr. 21, S. 2352 – 2360DOI (Open Access)
-
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma : An experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i)In: British Journal of Haematology, Jg. 196, 2022, Nr. 3, S. 606 – 616DOI (Open Access)
-
Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations : Comparison of the Deauville 5-Point Scale and the ΔSUVmₐₓ MethodIn: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 1, S. 37 – 42DOI (Open Access)
-
Interim PET in Diffuse Large B-Cell LymphomaIn: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 8, S. 1068 – 1074DOI (Open Access)
-
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell LymphomaIn: Journal of Clinical Oncology (JCO), Jg. 39, 2021, Nr. 23, S. 2605 – 2616DOI, Online Volltext (Open Access)
-
Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trialIn: Hematological Oncology, 2020DOI (Open Access)
-
Corrigendum to ‘Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial’ [Eur J Canc 124 (January 2020) 25–36] (European Journal of Cancer (2020) 124 (25–36), (S0959804919307555), (10.1016/j.ejca.2019.09.027))In: European Journal of Cancer (EJC), Jg. 136, 2020, S. 207 – 208
-
Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma : Post-hoc analysis from the PETAL trialIn: European Journal of Cancer (EJC), Jg. 124, 2020, S. 25 – 36
-
Etoposide combined with FLAG salvage therapy is effective in multiple relapsed / refractory acute myeloid leukemiaIn: Acta Haematologica, Jg. 143, 2020, Nr. 5, S. 438 – 445DOI (Open Access)
-
FDG-PET imaging for hodgkin and diffuse large b-cell lymphoma : an updated overviewIn: Cancers, Jg. 12, 2020, Nr. 3, S. 601DOI (Open Access)
-
Fertility preservation and fulfillment of parenthood after treatment of hematological malignancies : results from the ‘Aftercare in Blood Cancer Survivors’ (ABC) studyIn: International Journal of Clinical Oncology, Jg. 25, 2020, Nr. 6, S. 1187 – 1194DOI (Open Access)
-
Impact of complete surgical resection on outcome in aggressive non-Hodgkin lymphoma treated with immunochemotherapyIn: Cancer Medicine, Jg. 99, 2020, Nr. 22, S. 8386 – 8396DOI, Online Volltext (Open Access)
-
Metabolic tumor volume, cancer cell fraction, and prognosis–the case of T-cell/histiocyte-rich large B-cell lymphomaIn: Leukemia and Lymphoma, Jg. 61, 2020, Nr. 6, S. 1372 – 1379
-
Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determinationIn: Data in Brief, Jg. 28, 2020, 104976DOI (Open Access)
-
Serologic response to meningococcal vaccination in patients with cold agglutinin disease (CAD) in the novel era of complement inhibitionIn: Vaccine, Jg. 37, 2019, Nr. 44, S. 6682 – 6687
-
Characteristics of the relationship between MTV and survival in diffuse large B-cell lymphoma : A PETRA consortium study
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S357DOI (Open Access) -
Interim PET-Based Outcome Prediction in Diffuse Large B-Cell Lymphoma Patients Participating in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) Trial : Comparison of the Delta SUV Max Method and the Deauville 5-Point Scale
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 132, 2018, Nr. Supplement 1, S. 1696 – 1696DOI (Open Access) -
Molecular Characteristics of Diffuse Large B-Cell Lymphoma and Correlation with Baseline Metabolic Tumor Volume (MTV), Interim Positron Emission Tomography (iPET) and Outcome in the PETAL TrialIn: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 132, 2018, Nr. Supplement 1: 60th ASH Annual Meeting Abstracts, S. 4188 – 4188DOI (Open Access)